Own the gold standard ✨ in financial data & analytics
fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

Subscribe for $2
Overview
Profile

Aoxing Pharmaceutical Company stock price, quote, forecast and news

AOXG
US03740A1060
A1CUXU

Price

0.01
Today +/-
+0.00
Today %
+3.17 %
P

Aoxing Pharmaceutical Company stock price

%
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the Aoxing Pharmaceutical Company stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the Aoxing Pharmaceutical Company stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the Aoxing Pharmaceutical Company stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze Aoxing Pharmaceutical Company's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

Aoxing Pharmaceutical Company Stock Price History

DateAoxing Pharmaceutical Company Price
9/5/20240.01 undefined
9/3/20240.01 undefined
8/29/20240.01 undefined
8/23/20240.01 undefined
8/21/20240.01 undefined
8/20/20240.01 undefined
8/16/20240.01 undefined
8/12/20240.01 undefined

Aoxing Pharmaceutical Company Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Aoxing Pharmaceutical Company, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Aoxing Pharmaceutical Company from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Aoxing Pharmaceutical Company’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Aoxing Pharmaceutical Company. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Aoxing Pharmaceutical Company’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Aoxing Pharmaceutical Company’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Aoxing Pharmaceutical Company’s growth potential.

Aoxing Pharmaceutical Company Revenue, EBIT and net profit per share

DateAoxing Pharmaceutical Company RevenueAoxing Pharmaceutical Company EBITAoxing Pharmaceutical Company Net Income
201632.33 M undefined6.23 M undefined2.06 M undefined
201525.48 M undefined8.7 M undefined5.49 M undefined
201412.74 M undefined-3.33 M undefined-8.22 M undefined
201310.83 M undefined-6.55 M undefined-16.8 M undefined
20128.13 M undefined-1.15 M undefined-15.82 M undefined
20116.65 M undefined-4.86 M undefined-7.41 M undefined
20106.12 M undefined-3.59 M undefined-830,000 undefined
20098.94 M undefined-4.01 M undefined-2.7 M undefined
20087.07 M undefined-3.58 M undefined3.65 M undefined
20071.94 M undefined-1.41 M undefined-14.21 M undefined
20060 undefined-910,000 undefined-1.39 M undefined
20051.41 M undefined-90,000 undefined-370,000 undefined
20041.2 M undefined-150,000 undefined-240,000 undefined
20031.04 M undefined-200,000 undefined-280,000 undefined

Aoxing Pharmaceutical Company Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (M)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (M)EBIT (M)EBIT MARGIN (%)NET INCOME (M)NET INCOME GROWTH (%)SHARES (M)DOCUMENTS
20032004200520062007200820092010201120122013201420152016
111017866810122532
-----600.0014.29-25.00-33.3325.0020.00108.3328.00
--100.00--42.8637.5050.0050.0050.0060.0041.6776.0075.00
0010033334651924
0000-1-3-4-3-4-1-6-386
-----100.00-42.86-50.00-50.00-66.67-12.50-60.00-25.0032.0018.75
000-1-143-20-7-15-16-852
----1,300.00-121.43-166.67--114.296.67-50.00-162.50-60.00
0.20.250.2620.0320.0524.6241.245.5846.5849.3549.7549.8663.1175.47
--------------
Details

Keystats

ⓘ

Revenue and Growth

The Aoxing Pharmaceutical Company Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Aoxing Pharmaceutical Company is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (M)RECEIVABLES (M)OTHER REC. (k)INVENTORIES (M)OTHER CURRENT LIAB. (M)CURRENT ASSETS (M)TANGIBLE ASSETS (M)LONG-T. INVEST. (k)LONG-T. REC. (M)INTANGIBLE ASSETS (M)GOODWILL (M)OTHER NON-CURRENT ASSETS (M)NON-CURRENT ASSETS (M)TOTAL ASSETS (M)LIABILITIESCOMMON STOCK (k)ADDITIONAL PAID-IN CAPITAL (M)RETAINED EARNINGS (M)OTHER EQUITY (M)UNREAL. GAINS/LOSSES (M)EQUITY (M)LIABILITIES (M)PROVISIONS (M)OTHER SHORT-TERM LIAB. (M)SHORT-TERM DEBTS (M)LONG-TERM DEBT PORTION (M)SHORT-TERM REC. (M)LONG-T. LIAB. (M)DEFERRED TAXES (M)OTHER LIAB. (M)LONG-T. LIABILITIES (M)DEBT (M)TOTAL CAPITAL (M)
20032004200520062007200820092010201120122013201420152016
                           
0.090.140.0201.511.571.273.992.773.684.012.335.376.91
0.070.090.1300.112.541.061.722.012.82.843.895.7610.44
0000000750000089.32765.32
0.030.030.0300.220.850.711.561.471.812.622.23.242.84
00.0100.160.120.33.890.91.131.232.422.516.635.91
0.190.270.180.161.965.266.938.927.389.5211.8910.9221.126.87
6.295.55.3317.8219.2230.3329.3225.5726.6726.9626.9426.4228.6525.6
00000000521.54400.23292.27189.1996.484.2
00000000000000
000001.641.551.431.391.30.610.550.481.88
0000018.918.9319.0119.926.910000
00000003.3900002.711.88
6.295.55.3317.8219.2250.8749.849.448.535.5727.8427.1531.9429.36
6.485.775.5117.9821.1856.1356.7358.3255.8745.0939.7338.0753.0456.23
                           
20200404080805049.1649.6249.8249.8869.8476.21
10.3710.3810.424.34.8236.7539.149.5957.385858.358.3266.4673.63
-5.12-5.37-5.74-1.75-15.96-12.31-15.01-15.6-23.01-38.83-55.63-63.85-58.35-56.29
0.080.060.070.190.380.620.460.531.892.662.962.983.071.72
00000000000000
5.355.094.752.78-10.7225.1424.6334.5736.3121.885.67-2.5111.2419.14
0.070.10.140.790.93.542.822.972.662.764.123.883.872.71
0.270.210.2711.934.852.42.083.213.62.74.436.029.63
0000.031.130.113.870000.9900.910
0000.250.269.590.290.290.233.243.3111.414.1211.07
0.040.090.093.57.380.3810.738.228.549.0310.5714.516.3214.4
0.380.40.55.5711.618.4720.1113.5614.6418.6321.734.2141.2437.82
0.760.270.257.95.398.328.628.555.535.1913.087.51.370
00000000000000
000013.734.163.371.91000.370.370.370.34
0.760.270.257.919.1212.4811.9910.465.535.1913.457.871.740.34
1.140.670.7513.4730.7230.9532.124.0220.1623.8235.1542.0842.9838.16
6.495.765.516.252056.0956.7358.5956.4745.7140.8239.5854.2257.29
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of Aoxing Pharmaceutical Company provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Aoxing Pharmaceutical Company's financial health and stability.

Assets

Aoxing Pharmaceutical Company's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Aoxing Pharmaceutical Company must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Aoxing Pharmaceutical Company after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Aoxing Pharmaceutical Company's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M)DEPRECIATION (k)DEFERRED TAXES (M)CHANGES IN WORKING CAPITAL (k)NON-CASH ITEM (M)PAID INTEREST (M)PAID TAXES (M)NET CASH FLOW FROM OPERATING ACTIVITIES (M)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (M)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (M)NET CHANGE IN EQUITY (M)CASH FLOW FROM FINANCING ACTIVITIES (M)CASH FLOW FROM OTHER FINANCING ACTIVITIES ()TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (M)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
20032004200520062007200820092010201120122013201420152016
000-1-143-20-7-15-16-852
0000001,0001,0001,0001,0001,000001,000
000000-303000-20
0000001,0000000-1,0000-5,000
000011-52-30147001
00000000122432
00000000000000
0000-100-3-2-1-8-730
0000-1-1-2-2-1000-20
0000-1-17-2-10000-20
00000-1500000000
00000000000000
00003123128600
000001705000022
000031828128622
--------------
00000000000000
00001002-100-131
-0.27-0.15-0.12-0.81-2.17-2.46-2.87-5.98-4.05-2.08-8.76-80.32-0.65
00000000000000

Aoxing Pharmaceutical Company stock margins

The Aoxing Pharmaceutical Company margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Aoxing Pharmaceutical Company. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Aoxing Pharmaceutical Company.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Aoxing Pharmaceutical Company's sales revenue. A higher gross margin percentage indicates that the Aoxing Pharmaceutical Company retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Aoxing Pharmaceutical Company's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Aoxing Pharmaceutical Company's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Aoxing Pharmaceutical Company's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Aoxing Pharmaceutical Company. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Aoxing Pharmaceutical Company's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Aoxing Pharmaceutical Company Margin History

Aoxing Pharmaceutical Company Gross marginAoxing Pharmaceutical Company Profit marginAoxing Pharmaceutical Company EBIT marginAoxing Pharmaceutical Company Profit margin
201675.95 %19.26 %6.38 %
201577.67 %34.13 %21.56 %
201445.64 %-26.18 %-64.49 %
201357.87 %-60.47 %-155.17 %
201260.24 %-14.14 %-194.49 %
201149.97 %-73 %-111.42 %
201061.6 %-58.66 %-13.56 %
200942.62 %-44.85 %-30.2 %
200845.69 %-50.64 %51.63 %
200746.39 %-72.68 %-732.47 %
200675.95 %0 %0 %
200571.63 %-6.38 %-26.24 %
200468.33 %-12.5 %-20 %
200368.27 %-19.23 %-26.92 %

Aoxing Pharmaceutical Company Stock Sales Revenue, EBIT, Earnings per Share

The Aoxing Pharmaceutical Company earnings per share therefore indicates how much revenue Aoxing Pharmaceutical Company has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Aoxing Pharmaceutical Company earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Aoxing Pharmaceutical Company's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Aoxing Pharmaceutical Company’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Aoxing Pharmaceutical Company's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Aoxing Pharmaceutical Company Revenue, EBIT and net profit per share

DateAoxing Pharmaceutical Company Sales per ShareAoxing Pharmaceutical Company EBIT per shareAoxing Pharmaceutical Company Earnings per Share
20160.43 undefined0.08 undefined0.03 undefined
20150.4 undefined0.14 undefined0.09 undefined
20140.26 undefined-0.07 undefined-0.16 undefined
20130.22 undefined-0.13 undefined-0.34 undefined
20120.16 undefined-0.02 undefined-0.32 undefined
20110.14 undefined-0.1 undefined-0.16 undefined
20100.13 undefined-0.08 undefined-0.02 undefined
20090.22 undefined-0.1 undefined-0.07 undefined
20080.29 undefined-0.15 undefined0.15 undefined
20070.1 undefined-0.07 undefined-0.71 undefined
20060 undefined-0.05 undefined-0.07 undefined
20055.42 undefined-0.35 undefined-1.42 undefined
20044.8 undefined-0.6 undefined-0.96 undefined
20035.2 undefined-1 undefined-1.4 undefined

Aoxing Pharmaceutical Company business model

The Aoxing Pharmaceutical Company Inc is a Chinese company that specializes in the production and marketing of medical products. It was founded in 1996 and has since undergone rapid development. At the beginning, the company mainly produced traditional Chinese medicine (TCM) in a small production facility. However, with constant growth and increasing demand, the production facility was expanded and modernized. In 2004, Aoxing finally went public and was able to raise a large amount of money through the sale of shares. As a result, new technologies and state-of-the-art production facilities were acquired to further strengthen the company. The company's business model is based on the production and distribution of pharmaceuticals. Aoxing places great importance on research and development to constantly develop new medications and meet customer needs. At the same time, the company works closely with universities and research institutions to expand knowledge and technology in the field of medicine. For the international market, Aoxing is an important producer of opioid painkillers. These medications are essential for patients with severe pain and are used, for example, in cancer patients. This market is also becoming increasingly important in China as awareness of pain therapy gradually increases. Other important products of the company include antibiotics, cardiovascular medications, and medications for the treatment of infections and inflammations. Aoxing places great emphasis on quality and safety. All products are carefully tested and monitored to ensure they meet the highest standards. In recent years, Aoxing has also focused on the export market and has signed agreements with other countries. The company has achieved success, particularly in the United States, and has significantly increased its revenue in recent years. This expansion is an important step for the company to solidify its position in the global market. The company's divisions have also evolved. In addition to the production of medications, Aoxing has established its own research and development department and an IT team. The IT team has developed its own software to optimize work processes and increase efficiency. In the research department, new medications are being developed and tested for their effectiveness. The company is committed to making a contribution to society and the environment and adheres to strict environmental standards. Furthermore, it is interested in the well-being of its employees and advocates for a healthy work environment. Aoxing has launched several initiatives to improve the workplace and provide employees with a higher level of satisfaction. In summary, Aoxing Pharmaceutical Company Inc is a versatile company that focuses on the production of medications and constantly seeks new products and technologies. The company has embarked on an expansion course to continue growing in the coming years and conquer the international market. Aoxing Pharmaceutical Company is one of the most popular companies on Eulerpool.com.

Aoxing Pharmaceutical Company SWOT Analysis

Strengths

Aoxing Pharmaceutical Company Inc possesses several strengths that contribute to its success in the pharmaceutical industry. These include:

  • Strong Research and Development (R&D) capabilities
  • Wide range of product portfolio
  • Established distribution network
  • Strong financial position
  • Innovative approach to drug development
  • Strong track record in regulatory compliance

Weaknesses

Despite its strengths, Aoxing Pharmaceutical Company Inc faces certain weaknesses that may hinder its growth and competitive advantage. These include:

  • Limited global presence compared to larger competitors
  • Relatively low brand recognition
  • Dependence on key suppliers
  • Limited market share in specific drug categories
  • Higher production costs compared to some competitors

Opportunities

Aoxing Pharmaceutical Company Inc has several opportunities that it can leverage to further expand its market presence and profitability. These opportunities include:

  • Emerging markets with growing healthcare needs
  • Increasing demand for generic drugs
  • Partnerships and collaborations for research and product development
  • Expansion into new therapeutic areas
  • Investment in advanced manufacturing technologies

Threats

Aoxing Pharmaceutical Company Inc also faces certain threats that could negatively impact its business. These threats include:

  • Intense competition from established pharmaceutical companies
  • Stringent regulatory requirements and approvals
  • Risks associated with intellectual property infringements
  • Rapidly changing market dynamics and industry trends
  • Potential disruptions in the global supply chain

Aoxing Pharmaceutical Company Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

Aoxing Pharmaceutical Company historical P/E ratio, EBIT, and P/S ratio.

Aoxing Pharmaceutical Company shares outstanding

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Aoxing Pharmaceutical Company earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Aoxing Pharmaceutical Company's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Aoxing Pharmaceutical Company’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Aoxing Pharmaceutical Company's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Aoxing Pharmaceutical Company Stock splits

In Aoxing Pharmaceutical Company's history, there have been no stock splits.
Unfortunately, there are currently no price targets and forecasts available for Aoxing Pharmaceutical Company.

Aoxing Pharmaceutical Company latest earnings and earnings surprises

DateEPS EstimateEPS ActualQuarterly report
12/31/2010-0.03 0  (100 %)2011 Q2
9/30/2010-0.03 -0.01  (67.32 %)2011 Q1
3/31/2010-0.02 -0.02  (1.96 %)2010 Q3
1

Aoxing Pharmaceutical Company Executives and Management Board

Mr. Zhenjiang Yue58
Aoxing Pharmaceutical Company Chairman of the Board, Chief Executive Officer (since 2008)
Compensation 155,316
Mr. Guoan Zhang47
Aoxing Pharmaceutical Company Chief Financial Officer
Ms. Guirong Zhou63
Aoxing Pharmaceutical Company President - Research and Development
Mr. Jun Min58
Aoxing Pharmaceutical Company Director
Ms. Yang Li37
Aoxing Pharmaceutical Company Independent Director
1
2

Aoxing Pharmaceutical Company Supply Chain

NameRelationshipTwo-week correlationOne-month correlationThree-Month CorrelationSix-Month CorrelationOne Year CorrelationTwo-Year Correlation
American Oriental Bioeng Stock
American Oriental Bioeng
SupplierCustomer0,740,64----
Johnson Matthey Stock
Johnson Matthey
SupplierCustomer-0,19-0,42-0,67-0,050,11-
1

Most common questions regarding Aoxing Pharmaceutical Company

What values and corporate philosophy does Aoxing Pharmaceutical Company represent?

Aoxing Pharmaceutical Company Inc is driven by its core values of innovation, integrity, and quality. With a strong corporate philosophy, the company continually strives to offer advanced pharmaceutical solutions to improve the well-being of individuals worldwide. Aoxing Pharmaceutical focuses on research and development, delivering innovative and safe products to meet patient needs. The company maintains strict ethical standards and fosters a culture of transparency and accountability. Dedicated to excellence, Aoxing Pharmaceutical prioritizes the highest manufacturing and quality control standards in its operations. By embodying these values and corporate philosophy, Aoxing Pharmaceutical Company Inc has established itself as a trusted leader in the pharmaceutical industry.

In which countries and regions is Aoxing Pharmaceutical Company primarily present?

Aoxing Pharmaceutical Company Inc is primarily present in China.

What significant milestones has the company Aoxing Pharmaceutical Company achieved?

Aoxing Pharmaceutical Company Inc has achieved several significant milestones. It successfully obtained approval from the China Food and Drug Administration (CFDA) for its leading product, Tilidine Hydrochloride, which is used for the treatment of acute and chronic pain. Furthermore, the company received approval for its new drug, Nasal Naloxone Hydrochloride, from the CFDA, providing a breakthrough treatment for opioid overdoses. Aoxing Pharmaceutical has expanded its market presence by establishing strategic partnerships with international pharmaceutical companies, allowing for global distribution of its products. These achievements showcase the company's commitment to innovation and its drive to improve healthcare worldwide.

What is the history and background of the company Aoxing Pharmaceutical Company?

Aoxing Pharmaceutical Company Inc is a renowned pharmaceutical company with a rich history and background. Established in 1999, Aoxing Pharmaceutical has been committed to developing, manufacturing, and distributing innovative and high-quality drugs. With its headquarters in China, the company has grown to become a global leader in pain management and substance abuse treatment. Aoxing Pharmaceutical's dedication to research and development has resulted in a diverse product portfolio, including opioid drugs, traditional Chinese medicines, and opioid addiction treatment medications. With a strong focus on quality, safety, and customer satisfaction, Aoxing Pharmaceutical continues to contribute to the advancement of healthcare worldwide.

Who are the main competitors of Aoxing Pharmaceutical Company in the market?

Some of the main competitors of Aoxing Pharmaceutical Company Inc in the market include Pfizer Inc, Novartis AG, Johnson & Johnson, Merck & Co., Inc, and GlaxoSmithKline plc.

In which industries is Aoxing Pharmaceutical Company primarily active?

Aoxing Pharmaceutical Company Inc is primarily active in the pharmaceutical industry.

What is the business model of Aoxing Pharmaceutical Company?

The business model of Aoxing Pharmaceutical Company Inc is focused on the development, manufacturing, and distribution of pharmaceutical products. Aoxing Pharmaceutical Company Inc aims to provide high-quality and affordable medications to meet the growing needs of patients worldwide. By leveraging its research and development capabilities, Aoxing Pharmaceutical Company Inc strives to innovate and introduce new drugs to address various therapeutic areas. With a strong commitment to quality control and compliance, Aoxing Pharmaceutical Company Inc works towards enhancing healthcare outcomes and improving the overall well-being of individuals.

What is the P/E ratio of Aoxing Pharmaceutical Company 2024?

The P/E ratio cannot be calculated for Aoxing Pharmaceutical Company at the moment.

What is the P/S ratio of Aoxing Pharmaceutical Company 2024?

The P/S cannot be calculated for Aoxing Pharmaceutical Company currently.

What is the AlleAktien quality score of Aoxing Pharmaceutical Company?

The AlleAktien quality score for Aoxing Pharmaceutical Company is 4/10.

What is the revenue of Aoxing Pharmaceutical Company 2024?

The revenue cannot currently be calculated for Aoxing Pharmaceutical Company.

How high is the profit of Aoxing Pharmaceutical Company 2024?

The profit cannot currently be calculated for Aoxing Pharmaceutical Company.

What is the business model of Aoxing Pharmaceutical Company

The Aoxing Pharmaceutical Company Inc is a Chinese company that operates in the field of pharmaceutical research and development. It was founded in 1999 and is headquartered in Beijing. Aoxing Pharmaceutical specializes in three main business areas: pain medications, cancer therapies, and medications for heroin addiction. The company offers various products for pain relief, including Oxycondin, Tilidine, and Tramadol. It also focuses on researching and developing cancer therapies and medications that can help alleviate heroin withdrawal symptoms. In addition to these core business areas, Aoxing Pharmaceutical has a large network of distribution and marketing partners globally. The company prides itself on collaborating with renowned universities and research institutions, allowing it to tap into a wide range of expertise and experience. Aoxing Pharmaceutical's business model is centered around developing and introducing innovative medications while maintaining the highest standards of quality and safety. The company invests a significant portion of its revenue into research and development to improve healthcare worldwide. In summary, Aoxing Pharmaceutical is a leading company in the pharmaceutical industry, known for its specialized research areas and high-quality products. It aims to expand its presence both domestically and internationally.

What is the Aoxing Pharmaceutical Company dividend?

Aoxing Pharmaceutical Company pays a dividend of 0 USD distributed over payouts per year.

How often does Aoxing Pharmaceutical Company pay dividends?

The dividend cannot currently be calculated for Aoxing Pharmaceutical Company or the company does not pay out a dividend.

What is the Aoxing Pharmaceutical Company ISIN?

The ISIN of Aoxing Pharmaceutical Company is US03740A1060.

What is the Aoxing Pharmaceutical Company WKN?

The WKN of Aoxing Pharmaceutical Company is A1CUXU.

What is the Aoxing Pharmaceutical Company ticker?

The ticker of Aoxing Pharmaceutical Company is AOXG.

How much dividend does Aoxing Pharmaceutical Company pay?

Over the past 12 months, Aoxing Pharmaceutical Company paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Aoxing Pharmaceutical Company is expected to pay a dividend of 0 USD.

What is the dividend yield of Aoxing Pharmaceutical Company?

The current dividend yield of Aoxing Pharmaceutical Company is .

When does Aoxing Pharmaceutical Company pay dividends?

Aoxing Pharmaceutical Company pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Aoxing Pharmaceutical Company?

Aoxing Pharmaceutical Company paid dividends every year for the past 0 years.

What is the dividend of Aoxing Pharmaceutical Company?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Aoxing Pharmaceutical Company located?

Aoxing Pharmaceutical Company is assigned to the 'Health' sector.

Wann musste ich die Aktien von Aoxing Pharmaceutical Company kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Aoxing Pharmaceutical Company from 9/10/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 9/10/2024.

When did Aoxing Pharmaceutical Company pay the last dividend?

The last dividend was paid out on 9/10/2024.

What was the dividend of Aoxing Pharmaceutical Company in the year 2023?

In the year 2023, Aoxing Pharmaceutical Company distributed 0 USD as dividends.

In which currency does Aoxing Pharmaceutical Company pay out the dividend?

The dividends of Aoxing Pharmaceutical Company are distributed in USD.

All fundamentals about Aoxing Pharmaceutical Company

Our stock analysis for Aoxing Pharmaceutical Company Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Aoxing Pharmaceutical Company Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.